Biogen Inc. buy Royal Bank of Canada
Start price
31.07.23
/
50%
€245.60
Target price
31.07.24
€339.11
Performance (%)
-19.97%
End price
01.08.24
€196.55
Summary
This prediction ended on 01.08.24 with a price of €196.55. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.97%. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Biogen Inc. | -2.983% | -2.983% | -30.846% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $379.00 to $374.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten